News and price dashboard

Deal flow is the real story in the feed

The busiest thread today is M&A, and the largest is Silgan Holdings. Silgan is combining its Metal Containers segment and its Food and Beverage Flat Cap Closures business with Trivium Packaging, in a deal valuing Trivium at roughly $3.4 billion enterprise value. The combined entity, Silgan Metal Containers and Closures, leaves Silgan with 60% control while funds tied to American Industrial Partners put in about $1.0 billion of cash equity for the other 40%. Silgan takes roughly $2.3 billion in cash proceeds, earmarked for retiring debt, and says the deal should be at least 15% accretive to adjusted EPS and free cash flow with $225 million of synergies by year three. Its Dispensing and Custom Containers units get reorganised into a new wholly-owned Silgan Dispensing Solutions segment. The stock was up 5.6% pre-open on the news; Wells Fargo kept an Overweight rating while moving its target to $52. A separate headline-only item says Ardagh Group is selling its 42% stake in Trivium for $90 million, which is the other side of the same transaction.

MKS sells Ophir Optics to TTM

MKS is selling its Ophir Optics business to TTM Technologies for $650 million in cash, with both sides putting out releases. Ophir Optics makes high-precision infrared thermal imaging and laser optics for defence, security and industrial customers, operating from Israel and Romania. MKS frames the price as over 18 times projected FY2026 adjusted EBITDA for the unit and says the point is to capitalise on value created and strengthen the balance sheet; TTM describes the same price as about 10.3 times expected FY2027 adjusted EBITDA before synergies, and expects it to be immediately accretive to adjusted EBITDA margin and non-GAAP diluted EPS. TTM will fund it from cash, future cash flow and its revolver, alongside a previously announced $400 million capacity expansion in Asia. Closing is expected in Q2 2027. The deal excludes MKS's Ophir Instruments laser characterisation business and the Ophir brand itself. Worth noting the article pages show both tickers lower, MKSI around 6% and TTMI around 7%.

KKR exits railcar leasing to Ares

KKR is selling Infinity Transportation, an Atlanta-based railcar and intermodal lessor, to Ares Management for about $2.9 billion. Infinity owns and manages roughly 50,000 railcars leased to more than 350 customers across the US, Canada and Mexico, and KKR says book value is up 150% since 2021 under its ownership. Mike Roth of Ares Infrastructure Equity cited reshoring of manufacturing and demand for resilient supply chains as the rationale, and said Ares plans to support fleet growth after the expected Q1 2027 close.

Smaller deals and corporate actions

Data I/O is buying V-TEK and A&J Programming for about $23 million, paid in cash and roughly $3 million (about 1.12 million shares) of stock, funded partly from a previously announced $13.25 million securities offering, with closing expected this week. Osiris One Metals took an option on the Island Range copper-gold project on Vancouver Island, issuing 8 million shares for the vendor and committing to $1,375,000 of cash payments and $530,000 of expenditures over three to four years, plus an equal value in shares; the ground is 8,535 hectares near historic high-grade copper workings, with no resource defined. Headline-only items in the same vein: Centrus Energy buying Westerman for $116 million with shares climbing, Blackstone closing an $8.7 billion energy transition fund, Discovery Senior Living acquiring Sunshine Retirement Living, Valor Energy buying an 18MW computing centre in Ohio, and a Xerox shareholder pushing for a review of the financial services unit.

Biotech, mixed outcomes

argenx reported that its Phase 3 ALKIVIA study of VYVGART Hytrulo hit its primary endpoint in autoimmune myositis, with a 15.4-point greater improvement in mean Total Improvement Score versus placebo at week 52 (47.95 vs 32.56, p=0.0011) across the combined IMNM and dermatomyositis population, improvements showing from week 4 and holding through a mandated steroid taper. The trial randomised 265 patients, 175 treated in the Phase 3 portion, and the data go to ACR Convergence in November. There are no approved treatments for IMNM today. Going the other way, Enlivex is cutting about 60% of its workforce, winding down all R&D not tied to its Phase 2b Allocetra knee osteoarthritis trial, cutting management pay 20% and CEO pay 40%, with topline six-month data expected by mid-2027. Atossa shares began trading with one stapled contingent value right attached per share, entitling holders to 25% of net proceeds from the sale of its first qualifying priority review voucher, capped at $50 million and applying to a PRV awarded on or before 31 December 2036; no PRV has been awarded and no product is approved. Vaxart added retired Navy Vice Admiral Raquel Bono, former Director of the Defense Health Agency, to its board under a July 2026 cooperation agreement with a stockholder group. Headline-only biotech items include EyePoint cutting 53% of staff after a Phase 3 miss, FDA acceptances for UroGen in bladder cancer and CorMedix's rezafungin, a Clene NDA filing for ALS, J&J Tremfya Crohn's fistula data, and Biogen Empaveli data to come.

AI and chips under pressure

The backdrop across these pages is a tech selloff: the Nasdaq is shown down 2.14% and the S&P 500 down 1.09%, with the FTSE 100 off 1.18% and a headline attributing the UK slip to the US tech rout. Against that, Applied Digital rose 8% after Form 4 filings showed President Jason Zhang bought 300,000 shares on 16 October at a weighted average $18.86 and CEO and Chairman Wes Cummins bought 55,803 shares at $18.04, leaving Cummins with 5,874,453 shares directly plus 17.6 million held through Cummins Family Ltd. Headline-only items in this cluster: Goldman Sachs upgrading CoreWeave to Buy with a $106 target after a roughly 25% rout, JPMorgan lifting Intel on execution under Tan, a record $7 billion inflow into a leveraged chip fund during the selloff, Tenstorrent more than doubling its valuation to $6.2 billion, Morgan Stanley's Michael Wilson saying the selloff may be nearing its end, and Goldman flagging defensive positioning with its sentiment indicator at the 46th percentile.

Quantinuum error-correction claim

Quantinuum said it reached logical fidelity of 99.9995% on its Helios machine, about five errors per million operations, which it describes as ten times better than its own September record and a hundred times better than results Google Quantum AI reported on superconducting hardware. The result used a color code with up to 37 physical qubits per logical qubit, against 10 for the earlier Helix code, and logical errors fell by a factor of 12 with each increase in code distance. CEO Rajeeb Hazra said this proves the architecture needed for universal fault tolerance, and the company says the performance is in the target range for Apollo, its planned fault-tolerant machine due by 2029.

The rest of the feed

The remaining bulk of the 200 items is low-signal: a large number of TradingView chart posts on gold, Bitcoin, EURUSD and the indices, routine SEC filings (including a BioLargo DEF 14A with no content beyond the filing notice), Indian earnings call transcripts (ixigo, UltraTech, Oberoi Realty), and assorted small-cap announcements. Three macro headlines are worth flagging without claiming detail: oil prices dipping as Trump waives Russia sanctions, Iraq saying October exports have run near 3.4m b/d against ~3.7m pre-war, and major European telcos exploring a joint satellite spectrum bid.

What this feed mostly is

Of the 200 items here, the large majority are routine SEC filing notices and retail chart posts, not news. Roughly a third are Investing.com Form 4 director filings, and the twenty read in full were all either those filings or TradingView setups. The Form 4 items are worth saying plainly: the articles contain nothing beyond the headline. American Electric Power alone accounts for six separate director filings dated 30 September (McCarthy, Garcia, Fowke, Marriott, Meyers, Sauvage), ChoiceOne Financial four (Burrough, Burns, Brophy, Armock), IES Holdings four, Genesis Energy two, plus single filings from Ingredion and Neogen. No share counts, no transaction type, no prices appear in any of them. Headline-only Form 4s and 144s cover Republic Bancorp, Independent Bank, Peoples Bancorp, Norfolk Southern, Hasbro, Edison International, IBM, Shenandoah Telecom, Patriot National, Wayfair, Kinder Morgan, CarGurus and Circle.

Market snapshot carried inside those pages

The one genuinely useful thing in the Form 4 pages is the market panel embedded in each. WTI crude was up 3.95% at 99.02 while Brent sat at 109.69, down 0.15%, an unusual split. The S&P 500 was at 7,659.44, down 1.09%, and the Dow at 52,002.41, down 0.34%, against a firmer Europe and Asia: FTSE 100 up 0.38% to 10,881.90, DAX up 0.95%, Nikkei up 1.39%. Gold futures were 4,186.70, up 0.40%, silver flat at 57.14. US 10-year yield 5.098%, UK 10-year 5.3776%. London cocoa fell 3.23%. On the UK board, AstraZeneca was the heaviest faller among actives at minus 1.98%, Filtronic rose 13.94%, Nordex 14.37%, and the small-cap tail swung violently, Litigation Capital up 112% and Jarvis down 38%.

Headlines visible but not read

The same pages carry a popular-news list I saw only as headlines: Trump endorsing Netanyahu for reelection amid an Iran war, Microsoft pulling out of a UK data centre deal with Nscale per the Telegraph, tankers hit near Hormuz with Tehran offering a US reopening plan, and a note that Meta received a Street-high price target with Salesforce double upgraded. I have no detail behind any of those.

Corporate items in the headline-only pile

Three separate items say Anthropic is committing 5% of its shares to a new public benefit fund. Investing.com has a European Q3 earnings preview asking whether results can meet high expectations, carried twice. A transcript account quotes ASML's CFO saying price increases on its most critical equipment have been negotiated and concluded, with initial benefit in 2027 and fuller realisation from 2028, and quotes LVMH CFO Cécile Cabanis attributing a mid-single-digit decline in Asia to a sharp macro-led deterioration in Chinese consumer sentiment hitting discretionary spend. OilPrice has pieces on a nuclear power shortcut for the US grid and a Baluch insurgency escalating inside Iran.

The TradingView and social bulk

The remaining hundred-odd items are retail trading ideas, overwhelmingly gold, bitcoin, DXY and the major FX crosses, and they contradict each other freely. The two read in full are both from CAPTAINFX2: a US30 buy limit placed in a demand zone around 51,200 to 51,400 after a market structure shift and liquidity sweep, targeting near 54,735, and a EURUSD buy limit near 1.11548 to 1.12000 at the retest of a broken descending trendline. TradingView's own disclaimer on both notes these are not advice. The X posts are Musk promoting Grok, Ackman on false accusations and on Poland, White House border-crossing claims, and David Sacks on model refusals during cyber defence work. Nothing in that block is reported news.

What this feed actually is

Almost all 200 items here are filing stubs and chart posts rather than news. Twenty were read in full and nineteen of those turned out to be SEC Form 4 and Form 144 notices from Investing.com (Woodward directors Petryszyn, Paterson, Hess, Korte, Curado and Bhalla, Disney directors Chang, Gorman, Darroch, Everson, Barra, Froman and Lagomasino, plus Blackstone, Amazon, Janel, Netsol and three Bluerock Private Real Estate Fund trustees), and in every case the page carries only the headline and site furniture, with no share counts, prices or transaction detail in the body. So there is nothing to report from them beyond the fact that the filings exist.

Market levels carried on those pages

The one piece of hard data those pages do carry is the quote panel. At capture, FTSE 100 was 10,881.90, up 41.55 or 0.38%, DAX 25,622.61 up 0.95%, Nikkei 65,324.29 up 1.39%, while the S&P 500 was 7,659.44, down 84.62 or 1.09%, and the Dow 52,002.41, down 0.34%. WTI crude stood at 99.02, up 3.87 or 3.95%, with Brent roughly flat at 109.69; gold futures 4,186.70 up 0.40%, silver 57.14 flat, London cocoa down 3.23%. US 10-year was 5.098%, UK 10-year 5.3776%. That is a sidebar snapshot rather than reported news, but it is the real numbers behind a soft US session against firm Europe and Japan, and a sharp jump in WTI.

Iran and the Strait of Hormuz

The geopolitical thread runs through several headline-only items and the "most popular" lists on the pages read: Iran has appointed a new defence minister amid escalating tensions with the US, tankers have been hit near Hormuz, and Tehran has put forward a plan to reopen the strait. A separate headline says Iran is urging the US to accept that proposal, and an X post from DeItaone quotes Iran's foreign minister saying the seven-day proposal to reopen Hormuz is still on the table. Given WTI's near-4% move on the same page, this is the one live macro story in the section, though none of these items were read in full.

Other named news headlines

Headline-only, without the underlying detail: Microsoft has pulled out of a UK data centre deal with Nscale, per the Telegraph, carried by two outlets; Ledger crypto wallets were compromised in a hardware attack linked to a $90m theft; China has proposed export curbs on 12 key solar manufacturing technologies; Russia struck Ukraine's energy sector 76 times in a week according to Zelenskiy; ICICI Bank's ADR earnings missed with revenue in line; EOS fell 11%; and an analyst round-up flags a Street-high price target on Meta and a double upgrade for Salesforce. An IMF/World Bank meetings analysis is described as leaving developing countries with more questions than answers.

Insider transactions with figures

A few of the insider headlines do carry numbers: Princeton Bancorp director Martin Tuchman sold $95,160 of shares, Flexsteel director William Creekmuir sold over $101,000, and Olesen Value Fund sold $716,664 of Solitron Devices. At the other end, two RGC Resources officers bought token amounts, $200 and $100.

The TradingView bulk

Roughly half the remaining list is TradingView chart commentary on gold, bitcoin, the dollar index, EURUSD, GBPUSD and assorted alt-coins, titled as setups and weekly outlooks. These are individual authors' technical posts, not reporting, and there is no substance in them beyond the headlines shown.

What the full-text items actually were

Twenty items in this section were pulled in full, and all twenty turned out to be Investing.com Form 144 stubs — Airbnb, Carvana, CoreWeave, Core Scientific, Zoom, Nutanix, Procore, Dropbox, Figma, Life360, Castle Biosciences, Heartflow, BillionToOne, Myomo, Aeluma, Zevra, Oruka, Everpure and VTEX (filed twice). A Form 144 is notice of a proposed insider sale. These particular pages contain no share counts, no seller names, no dollar values and no commentary at all beyond the headline itself, so there is nothing further to tell you about any of them. The only numbers on the pages are the site's own quote panel, which is the same on every one.

Market panel carried on those pages

That shared panel, for what it's worth, showed the S&P 500 at 7,659.44, down 1.09%, and the Dow at 52,002.41, off 0.34%, against a firmer Europe and Asia: FTSE 100 up 0.38% to 10,881.90, DAX up 0.95%, Nikkei up 1.39%. WTI crude was the standout at 101.84, up 3.95%, with Brent roughly flat at 109.69. Gold futures 4,186.70, up 0.40%, silver effectively unchanged at 57.14. US 10-year at 5.098%, UK 10-year at 5.3776%. London cocoa fell 3.23%.

Insider sales and buys, headline level

A cluster of insider headlines carries actual figures. Gilead chairman and CEO Daniel O'Day sold $2.2m of stock; Anterix CFO Elena Marquez sold $400,606 in the $80.00 to $82.50 range; Saba Capital sold $675,333 of BlackRock ECAT. On the buy side, Pedevco director Simon Kukes bought $1.91m of company stock, and Tether's global investments fund bought $1.28m of Gold.com stock. The largest single line is GIC Private selling $274.8 million of Medline shares. Each of these is headline-only, so the reasoning behind them isn't in the feed. Alongside sits a long tail of routine Form 4 and Form 144 filings — Microsoft, Salesforce, Palantir, Applied Materials, Workday, Snowflake, Atlassian, JPMorgan, Clorox, Lennar, McCormick, eight separate Bayfirst Financial directors — with nothing attached but the name and date.

The handful of real news headlines

A few genuine news lines sit in here, all headline-only. DeepSeek released an AI model update and opened its search APIs to all users. Mercedes unveiled an electric SUV as it expands its premium EV line. Investing.com ran a piece asking whether the wall of worry around memory stocks is justified, and another noting the SOX chip index has posted its longest losing streak since 2008 on deepening AI worries. A post flagged that the US government will take roughly a 4% equity stake in GlobalFoundries alongside a restructuring of its CHIPS award. OilPrice has Europe bracing for a winter energy crunch on low gas reserves, Bolivia's gas reserves running dry, and a piece on Permian wastewater being studied to cool AI data centres.

The rest is retail chart posts and political noise

Well over half the section is TradingView user content — directional calls on gold, bitcoin, EURUSD, silver, the S&P and US100, plus crypto buy-limit posts and a few how-to pieces on market structure and stop hunts. These are individual traders' own views, not reporting. The remainder is Trump Truth Social endorsement posts for various Senate and House candidates, White House and Elon Musk posts, and a set of quote-clips from JPMorgan's Dimon, Morgan Stanley's CFO on AI cutting manual finance work, LVMH's CFO rejecting price cuts at Louis Vuitton, and Constellation Brands' CEO calling World Cup sales weaker than the industry expected. Nothing in that group has substance behind it that this feed gives you.

What this feed actually is

Of the 200 items here, the large majority are routine regulatory filings and retail chart posts, not news. Twenty were read in full and nineteen of those turned out to be Investing.com Form 4 and Form 144 stub pages that carry only a title, a date and the site's boilerplate, with no transaction figures in the body at all: Covista, STAG Industrial (three directors), ESCO Technologies (six directors), Choice Hotels (two directors), Tidal Trust II, Elevation Series Trust, SPDR Series Trust, FT 13246, and Form 144s for AvePoint and Block. There is nothing to report from those beyond the fact that the filings exist.

The one filing with real detail

The exception is Nuveen Municipal Credit Income Fund, which appears twice in the feed from the UK and US editions of the same article. Trustee Terence J. Toth sold 6,677 common shares on 14 October at $10.755, roughly $71,811, and now directly holds zero shares. The piece notes the fund was trading at $11.03, slightly above his sale price, and cites InvestingPro data putting the yield at 8.65% with dividends maintained for 26 straight years. No reason for the sale is given, and the article says it was AI-generated and editor-reviewed.

Market backdrop visible in the pages

The market data carried on those same pages gives a consistent snapshot: FTSE 100 at 10,881.90, up 0.38%, DAX up 0.95%, Nikkei up 1.39%, against an S&P 500 at 7,659.44, down 1.09%, the Dow down 0.34% and the Nasdaq down 2.14% to 26,140.03, with VIX up 21.45% to 19.99. WTI crude was up 3.95% at 101.84 while Brent slipped slightly to 109.69. Gold futures at 4,186.70, up 0.40%. US 10-year at 5.098%. On the US movers list the damage was concentrated in AI-linked names: Nebius down 12.18%, CoreWeave down 11.91%, Super Micro down 9.86%, MicroStrategy down 9.56%, Micron down 5.63%, while energy and defence led the gainers with Targa up 4.37%, Diamondback 4.27%, Kinder Morgan 4.20%, Northrop 4.05% and Lockheed 3.65%.

The AI-trade headlines around it

Several headline-only items point the same direction, and I've only got the headlines on these: the SOX chip index posting its longest losing streak since 2008 as AI worries deepen, the Nasdaq notching its worst week since late June with a 4.5% slide, Barclays' Cau saying the best of the AI trade may be over, a Goldman note flagging two memory stocks to buy amid the sector pullback, BofA advising staying risk-off on higher real yields and AI volatility, Citi seeing resilient demand for Chinese AI IPOs, and a chip-stocks piece drawing a comparison to the 2000 analog. Against that, two posts of Anthropic's Jack Clark saying an internal model projects AI could lift US GDP from $30 trillion to $44 trillion by 2030, with the caveat that capability is advancing faster than intuitions about it.

Insider sales, headline level

Beyond the Nuveen piece, a run of insider-sale headlines with dollar figures but no detail I can vouch for: Moderna president Stephen Hoge $17m, IDT director Judah Schorr $1.12m in class B stock, NWPX Infrastructure director Roman $387k, BJ's Wholesale CFO Felice $887k, Gilead's chief communications and corporate affairs officer $468,660, Take-Two director Siminoff $67,775, Beta Bionics CCO Hopman $13,446, and Bank of America buying $16.2k and selling $15.4k of a PIMCO fund. Also present, headline only: Raymond James upgrading Greif to Outperform from Market Perform.

Macro and earnings headlines

Headline-only again: UK bank shares falling on a report of a possible tax hike in the 28 October budget, UK-US relations strained as Trump shifts stance on the Russia-Ukraine war, a German minister seeking a debt brake exemption to maintain Ukraine aid, Russia saying it struck Ukrainian steel plants and power infrastructure, and delegates walking out of an IMF steering committee meeting when a Russian official spoke. On earnings, ICICI Bank Q2 profit beating estimates on strong loan growth, HDFC Bank Q2 profit up 5% with net interest income growing, plus an HDFC call transcript headlined as margin pressure easing.

The chart-post bulk

Roughly half the feed is TradingView user posts, overwhelmingly gold and bitcoin setups pointing in opposite directions on the same instruments, plus scattered calls on EURUSD, GBPJPY, silver, META, GOOGL, MSFT and various altcoins. These are individual traders' own charts, not reporting, and there's nothing in them to summarise for you.

Risk-off session led by the AI complex

The backdrop to almost everything in this feed is a sharp risk-off day in US tech. Market data carried in the Investing.com pieces shows the Nasdaq down roughly 2.1-2.2% to about 26,140, the S&P 500 off 1.1-1.25%, the Dow down 0.34%, and the VIX up 22-30% to around 20-21. The site's own headlines frame it as the Nasdaq's worst week in over 18 months, with the AI trade the stated culprit. The damage was concentrated: CoreWeave down 11.9%, Nebius down 12.2%, Super Micro down 9.9%, MicroStrategy down 9.6%, Palo Alto down 7.7%, Rocket Lab down 8%, Micron down 5.6%, Meta down 3.7%. Energy and defense went the other way, with Diamondback, EOG, APA, Kinder Morgan and Targa all up around 4%, and Northrop up 4.1%, RTX 3.7%. The FTSE 100 closed up 0.38% at 10,881.90 for a second weekly gain, led by defense names, and the DAX rose 0.94%.

A long list of 52-week lows

Much of the full-text material is Investing.com's automated 52-week-low coverage, and the names cluster in exactly the parts of the market that got hit. Pony AI hit $4.93, down 78% from its $22.46 high and 74% over a year, with 14.4% of that drop coming in the past week alone; the piece notes Q2 revenue of $36.2m, up 69% and ahead of the $35.2m consensus, robotaxi fare revenue up 849% year on year, continued losses, BofA cutting its target to $17 from $19 while keeping Buy, and Jefferies at $32.80. JetBlue touched $2.98, down nearly 18% in a week and 43% over six months; the article cites its raised Q3 RASM guidance of 17-20% growth against a prior 12.5-16.5%, but non-fuel CASM up 6-8%, and Susquehanna cutting targets across Delta, United and American on higher fuel costs through 2027. Infleqtion hit $8.51, down 59% over a year, with a "WEAK" financial health score despite Q2 revenue of $12.6m (up 116%) and full-year guidance raised to about $43m. Mesoblast fell to $13.03, 39% below its high, after $115m of FY26 revenue in its first full commercial year with Ryoncil. Rivian hit $12.39, down 34% year to date, with the piece noting Q3 deliveries of 19,248 and production of 19,751, both ahead of consensus. Vistance Networks hit $5.84 against a $20.55 high, with earnings due in 13 days. Apollo touched $25, though the article points out a positive 1-year total return of 2.56%, a 7.55% dividend yield and a $66bn market cap. AGNC and American Financial Group also appear as a low and a high respectively, headline-only.

Rock Tech Lithium, from two angles

Rock Tech Lithium rose 5.1% to C$0.62, off a C$0.54 52-week low. The full article says there was no fresh company news that day and attributes the move to a technical rebound plus two earlier items: preliminary Definitive Feasibility Study results on October 7 for the Red Rock Converter in Ontario, showing capital costs of about C$596m for roughly 30,000 tonnes a year of lithium salts, with CEO Mirco Wojnarowicz calling it an important decision-making milestone, and a C$6m private placement closed October 9 for Georgia Lake, Red Rock and working capital. Final DFS results are due December 2026. Worth noting alongside it, a headline-only item says Rheinmetall has taken a stake in Rock Tech Lithium and a German plant, which the feature article does not mention.

Insider filings and Form 4 noise

A large share of the feed is routine SEC filing coverage with no market content. Three German American Bancorp directors bought through the dividend reinvestment and stock purchase plan at $49.6635 on October 15: Zachary Bawel 344.3173 shares for $17,100, Christina Ryan 2.0136 shares for $100, and Andrew Seger for $100 (headline only). These are elections to take director compensation in stock, not discretionary open-market buys. The stock trades at $50.05, up 29% year to date, with a 2.5% yield and 13 straight years of dividend increases. Elsewhere, Aquestive Therapeutics' CEO sold $105,600, a Kaltura officer sold $15,220, and MDB Capital's co-founder bought $1,769. The Form 4 items for Disney, Ford, Amazon, AMD, Marvell and various ETFs carry no detail beyond the filing itself.

Corporate and policy headlines, unread

Several headline-only items are worth knowing exist. SoftBank is reported to be weighing a $30bn deal for Allied Universal. Anduril says it may produce new Steelfin missiles, or interceptors, in Europe. The US fiscal 2026 budget deficit came in at $1.99 trillion, the largest in five years, though a separate headline says the federal deficit narrowed more than expected. The European Commission plans to propose further import curbs on Chinese sectors. Novartis ended a mid-stage trial of Fabhalta in lupus nephritis. The FAA is set to approve the 737 MAX 10 as soon as next week, and separately banned unauthorized drones along the US-Mexico border. A US appeals court blocked class actions over Tesla's self-driving claims. Snowflake and Okta both have "why is the stock tumbling" pieces, as do the semiconductor ETFs, QQQ, SPY and the Russell 2000 ETF, all consistent with the broad selloff. Anthropic says Claude solved a 25-year cryptography problem in 30 minutes. California reported nearly 12,000 EV purchases under its new rebate program.

Commodities and the rest

Oil is high and moving: WTI around $101.3-101.6 and Brent near $109.5, with intraday prints showing WTI up 3.4% at one point. Gold futures sat near $4,186-4,189, silver around $57.14, copper $6.56. Javier Blas posted that Dated Brent plunged about $10 a barrel and that North Sea physical premia saw one of the largest one-day drops on record, which sits oddly against the futures strength and is only a headline. US 10-year yields were about 5.08%, the 10-2 spread widened 15% to 31bp. Agricultural headlines are routine: wheat and sugar lower, corn soft, cotton and hogs higher, cocoa retreating on weaker North American demand. The remaining bulk of the 200 items is TradingView chart posts and social media noise, which carry no verifiable content.